Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Invitae Corp (NVTA)

Invitae Corp (NVTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,593,438
  • Shares Outstanding, K 199,837
  • Annual Sales, $ 279,600 K
  • Annual Income, $ -602,170 K
  • 60-Month Beta 1.90
  • Price/Sales 20.07
  • Price/Cash Flow N/A
  • Price/Book 2.34
Trade NVTA with:

Options Overview

Details
  • Implied Volatility 54.10%
  • Historical Volatility 45.63%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 113.74% on 03/08/21
  • IV Low 54.10% on 08/05/21
  • Put/Call Vol Ratio 1.15
  • Today's Volume 1,904
  • Volume Avg (30-Day) 3,832
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 156,879
  • Open Int (30-Day) 147,781

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.65
  • Number of Estimates 6
  • High Estimate -0.44
  • Low Estimate -0.78
  • Prior Year -0.77
  • Growth Rate Est. (year over year) +15.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.02 +18.64%
on 07/27/21
34.11 -9.50%
on 07/06/21
-2.49 (-7.46%)
since 07/02/21
3-Month
25.24 +22.31%
on 05/13/21
35.51 -13.07%
on 06/28/21
-0.36 (-1.15%)
since 05/05/21
52-Week
25.24 +22.31%
on 05/13/21
61.59 -49.88%
on 12/14/20
-2.49 (-7.46%)
since 08/05/20

Most Recent Stories

More News
Pharming Group reports financial results for the first half of 2021

Recovery continued into Q2 2021 as patient enrollment and product demand increases

PHGUF : 1.1500 (unch)
NVTA : 30.87 (-0.16%)
S&P Off Record High, Dow Down 300 Points as Jobs Data Begins

S&P Off Record High, Dow Down 300 Points as Jobs Data Begins

DRVN : 29.25 (-5.49%)
CWH : 43.44 (+1.14%)
RUTH : 19.75 (+0.97%)
KMT : 36.47 (+1.90%)
EXPI : 49.42 (+4.55%)
EDIT : 54.51 (+18.37%)
NVTA : 30.87 (-0.16%)
PACB : 35.02 (+8.99%)
Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates

Invitae (NVTA) delivered earnings and revenue surprises of -30.77% and 6.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NVTA : 30.87 (-0.16%)
Invitae: Q2 Earnings Snapshot

SAN FRANCISCO (AP) _ Invitae Corp. (NVTA) on Tuesday reported a loss of $129 million in its second quarter.

NVTA : 30.87 (-0.16%)
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021

/PRNewswire/ --  (NYSE: NVTA), a leading medical genetics company, today announced preliminary financial and operating results for the second quarter ended and increases 2021 guide to revenue between...

NVTA : 30.87 (-0.16%)
2 Healthcare Stocks Wall Street Predicts Will Rally by 40% or More

The healthcare industry’s relatively inelastic demand and its crucial role in fighting the COVID-19 pandemic will likely make it a popular choice for investors seeking to hedge their portfolios against...

NVTA : 30.87 (-0.16%)
OPK : 3.76 (+3.87%)
Bear of the Day: NeoGenomics (NEO)

Emerging diagnostics provider is steadily growing sales and key M&A but ran into an EPS cliff

NEO : 47.71 (+0.46%)
EXAS : 108.02 (+2.07%)
NVTA : 30.87 (-0.16%)
NTRA : 119.64 (+4.47%)
GH : 115.39 (+1.35%)
PacBio (PACB) Enhances Sequencing Platform Via Latest Buyout

PacBio's (PACB) latest acquisition is expected to deliver the most advanced blend of sequencing solutions to transform the genomics landscape.

HSIC : 76.73 (-0.74%)
PACB : 35.02 (+8.99%)
VEEV : 341.00 (+0.01%)
NVTA : 30.87 (-0.16%)
Volpara Collaborates With Invitae Corporation, Leading Genetics Company

/PRNewswire/ -- Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation,...

NVTA : 30.87 (-0.16%)
Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021

/PRNewswire/ --  (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2021 financial results on and will host a conference call and webcast that day...

NVTA : 30.87 (-0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.

See More

Key Turning Points

3rd Resistance Point 32.79
2nd Resistance Point 32.21
1st Resistance Point 31.54
Last Price 30.87
1st Support Level 30.29
2nd Support Level 29.71
3rd Support Level 29.04

See More

52-Week High 61.59
Fibonacci 61.8% 47.70
Fibonacci 50% 43.42
Fibonacci 38.2% 39.13
Last Price 30.87
52-Week Low 25.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar